GLP-1, or glucagon-like peptide-1, is [] GLP-1 therapy, when paired with the right exercise routine, accelerates weight loss and amplifies overall health improvements for overweight adults
Circ Res (2014) 114(6):100421
Phase 2 trial data published in 2023 showed participants receiving the highest retatrutide dose lost an average of approximately 24 percent of body weight over 48 weeks, which exceeded results seen with dual-agonist medications in comparable timeframes
doi: 10.1111/dom.12473 24 NauckMAEl OuaghlidiAHompeschMJacobsenJElbroendB
Pauses in breathing during sleep
Chiang CH, Song J, Chang YC, Osataphan S, Lee YC, Chang KY, et al